Comparison of erythromycin base and estolate in gonococcal urethritis

Area of Science:

• Infectious Diseases
• Pharmacology
• Clinical Trials

Background:

• Gonococcal urethritis remains a significant public health concern.
• Penicillin-allergic patients often require alternative antibiotic treatments.
• Erythromycin, in different formulations, has been considered for treating gonorrhea.

Purpose of the Study:

• To compare the therapeutic efficacy of erythromycin estolate versus erythromycin base in treating gonococcal urethritis.
• To evaluate treatment outcomes in men receiving a 9-gram course of erythromycin.
• To assess serum erythromycin activity in relation to treatment efficacy.

Main Methods:

• A randomized, double-blind clinical trial was conducted.
• 152 men diagnosed with gonococcal urethritis participated.
• Participants were treated with either erythromycin estolate or erythromycin base.

Main Results:

• Treatment success rates were similar between the two groups: 24% (21/86) for estolate and 23% (15/66) for base.
• Recurrent or persistent gonococcal infection was observed in both treatment arms.
• Serum erythromycin activity was nearly double in the estolate group compared to the base group.

Conclusions:

• Neither erythromycin estolate nor erythromycin base demonstrated superior efficacy for gonococcal urethritis in this trial.
• The findings do not support the routine use of erythromycin for treating gonorrhea, particularly in pregnant, penicillin-allergic individuals.
• Further research may be needed to identify optimal treatment strategies for specific patient populations.